EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Overcoming the challenges of a misdiagnosed rare lung disease - Idiopathic pleuroparenchymal fibroelastosis

Shivam Garg, Pratap Upadhya, Arul Kumar, Norton Stephen, Bala Subramanian

Monaldi Archives for Chest Disease · 2023

DOI: 10.4081/monaldi.2023.2632 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Monaldi Archives for Chest Disease, 2023. Verfasst von Shivam Garg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. shivjmv@gmail.com. Hauptthemen laut MEDLINE: Diagnostic Errors, Pleural Diseases, Pulmonary Fibrosis, Rare Diseases. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pleuroparenchymal fibroelastosis (PPFE) is a rare condition characterized by pleural and subpleural lung fibroelastosis with an upper lobe predominance. We present the third case of idiopathic pleuroparenchymal fibroelastosis (IPPFE) from India, as well as the second antemortem diagnosis. A 27-year-old man presented with a one-year history of mMRC class II dry cough and shortness of breath. He described a fifteen-kilogram weight loss. After a clinico-radiological diagnosis, he was given anti-tubercular treatment and referred because he showed no improvement. A high-resolution computed tomography of the chest revealed bilateral upper lobe bullae, parenchymal and subpleural fibrosis, and irregular pleural thickening. PPFE was found in surgical lung and pleural biopsies. He was given systemic glucocorticoids but did not respond clinically or radiologically. Pirfenidone and a lung transplant were out of reach for him. He died nine months after being diagnosed with his condition. Finally, IPPFE is an extremely rare entity, with only three cases reported from our subcontinent. As a result, it is easily underdiagnosed or misdiagnosed; clinician awareness of this condition is critical for better diagnosis and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diagnostic ErrorsPleural DiseasesPulmonary FibrosisRare DiseasesAdultHumansMaleBiopsyFatal OutcomeGlucocorticoidsIndiaLungLung TransplantationPleuraPyridonesTomography, X-Ray Computed

Substanzen

GlucocorticoidspirfenidonePyridones

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. shivjmv@gmail.com.
  • Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. drpratapujipmer@gmail.com.
  • Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. arul1022@gmail.com.
  • Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. norton.divya@gmail.com.
  • Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. balasm1610@gmail.com.

Zitieren

APA

Garg, S., Upadhya, P., Kumar, A., Stephen, N., & Subramanian, B. (2023). Overcoming the challenges of a misdiagnosed rare lung disease - Idiopathic pleuroparenchymal fibroelastosis. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2023.2632

Vancouver

Garg S, Upadhya P, Kumar A, Stephen N, Subramanian B. Overcoming the challenges of a misdiagnosed rare lung disease - Idiopathic pleuroparenchymal fibroelastosis. Monaldi Archives for Chest Disease. 2023. doi:10.4081/monaldi.2023.2632

BibTeX
@article{Garg2023,
  author = {Garg, Shivam and Upadhya, Pratap and Kumar, Arul and Stephen, Norton and Subramanian, Bala},
  title = {Overcoming the challenges of a misdiagnosed rare lung disease - Idiopathic pleuroparenchymal fibroelastosis},
  journal = {Monaldi Archives for Chest Disease},
  year = {2023},
  doi = {10.4081/monaldi.2023.2632}
}
Kostenlos starten →